Arvinas Inc. (ARVN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Arvinas Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$7.60
+2.01% today
Market cap
$487M
Overall quality
61/100
Kronos AI 30-day
+8.3%
8 of 8 simulated paths end higher
Arvinas Inc. (ARVN) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $487M. It trades at $7.60, up 2.01% today, at 54.5 times earnings. Its overall quality score is 61 out of 100, ranked against the whole US market. 11 analysts' average target of $15.07 implies +98.3% from today's price. Kronos AI's 30-day forecast is +8.3% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $15.07 |
| Low – high | $8.68 – $21.00 |
| Analysts | 11 |
| Upside to average | +98.3% |
Kronos AI 30-day forecast
| Expected close | $8.07 (+8.3%) |
| Likely range | +3.8% … +9.8% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 35 |
| Solvency | 61 |
| Growth | 87 |
| Overall | 61 |
| P/E | 54.5 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.